Diabetes & Endocrinology Perspective

 
 

  • Heart Failure Guidelines Update: What the ESC Got Right   Heart failure specialist Dr Ileana Piña discusses what she likes about the 2023 ESC focused update to the heart failure guidelines.
  • Is AF Ablation the Fifth Pillar in Heart Failure Care?   John Mandrola interviews CASTLE-Htx investigators, Christian Sohns, and Philipp Sommer about the role of ablation in patients with AF and end stage heart failure.
  • Left-Digit Bias and Other Random Acts of Medicine   A new book reveals how chance can change the course of a person's health, life, and death.
  • Infographic: Doctors Act Out on Social Media, Peers See It Physicians discuss how they see other doctors posting on social media in ways they may regret, and which platforms have the biggest issues.
  • Change Makers: Elcin Barker Ergun on Healthcare Renaissance WebMD Chief Medical Officer John Whyte, MD, MPH, speaks with Elcin Barker Ergun, CEO of the Menarini Group, in Florence, Italy, about what they believe to be a new renaissance in healthcare.
  • The New Normal in Body Temperature   Are humans more cold-blooded than we have always believed? F. Perry Wilson reviews a study of "normal" oral temperatures in adults.
  • Less Dopamine, More Eating? Low levels of dopamine have been associated with binge eating. Caroline Messer, MD, explains why and how to consult with these patients.
  • Sep 01 2023 This Week in Cardiology   ESC Wrap-up 1: Obesity, heart failure with preserved EF and reduced EF, AF, frailty, evidence translation, and catheter ablation are the topics John Mandrola, MD, discusses in this week’s podcast.
  • 'Decapitated' Boy Saved by Surgery Team   Dr F. Perry Wilson spoke with Dr Ohad Einav, the Israeli surgeon who repaired a boy's internal decapitation, the result of being struck by a car when riding his bike in the West Bank.
  • The Most Important Study From ESC If you treat patients, no trial at ESC is more important, according to John Mandrola, MD. The results of FRAIL-AF demonstrate the value of humility in science and the practice of evidence-based medicine.
  • Medscape Medical Student Lifestyle Report 2023 Medical students reveal their concerns about job stress, financial worries, and work-life balance, among other issues. They also tell how consistently they feel burned out and what they do about it.
  • Semaglutide's Big STEP in HFpEF With Obesity   The GLP-1 receptor agonist semaglutide led to weight loss and improved quality of life in patients with heart failure with preserved ejection fraction and obesity.
  • Unlocking the Secrets of Brown Fat Brown fat is a "nutrient sink" that could play an important role in glucose and even glutamate metabolism, and may offer a target for tackling obesity and potentially even cancer, suggests US research.
  • ESC 2023 AF Ablation in End-Stage HF: Too Good to Be True? Patients with AF and end-stage heart failure saw a dramatic early benefit from ablation. Some question the findings but others see a subset of patients for whom sinus rhythm makes a big difference.
  • Metabolic Inflexibility: More Than 'Energy In, Energy Out' How is energy used? Metabolic flexibility is the body's ability to adjust to changes in energy, and it plays an important role in people with diabetes and obesity.
  • Really? Cancer Screening Doesn't Save Lives?   You might have a hard time believing that all this cancer screening is for nothing. See what Perry thinks.
  • Infographic: Realities of Working as an Employed Physician Doctors who work for healthcare organizations and other employers tell of their happiness with their salaries, the importance of respect for their contributions, and where they would go for a new job.
  • Global Health Professionals Must Continue to Prevent Nuclear War A meaningful medical response to nuclear war is wishful thinking. Healthcare professionals, who know this better than anyone, must unite to prevent such a catastrophe.
  • ESC 2023 Pulsed Field Ablation for AF Underwhelming in ADVENT Pulsed field ablation did not live up to the hype and enthusiasm of European colleagues, according to this US-based electrophysiologist, but the results of ADVENT are likely sufficient for FDA approval.
  • ESC 2023 Semaglutide in HFpEF Cleared a Low Bar Patients with heart failure with preserved ejection fraction and obesity lost weight and felt better while taking semaglutide vs placebo, but was the bar for success set too low in STEP-HFpEF?
  • EASD 2022
  • ECO 2022
  • DUKPC 2022
  • SfE BES 2021
  • DPC 2021
  • EASD 2021
  • DPC 2020
  • DUKPC 2021
  • EASD 2020